NO306536B1 - Senkning av tromboksannivå ved perkutan tilförsel av aspirin - Google Patents
Senkning av tromboksannivå ved perkutan tilförsel av aspirinInfo
- Publication number
- NO306536B1 NO306536B1 NO933529A NO933529A NO306536B1 NO 306536 B1 NO306536 B1 NO 306536B1 NO 933529 A NO933529 A NO 933529A NO 933529 A NO933529 A NO 933529A NO 306536 B1 NO306536 B1 NO 306536B1
- Authority
- NO
- Norway
- Prior art keywords
- aspirin
- lowering
- percutaneous administration
- thromboxane levels
- thromboxane
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001138 acetylsalicylic acid Drugs 0.000 title abstract 2
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68019591A | 1991-04-03 | 1991-04-03 | |
| PCT/US1992/002576 WO1992020343A1 (fr) | 1991-04-03 | 1992-04-02 | Abaissement des taux de thromboxane par administration percutanee d'aspirine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO933529D0 NO933529D0 (no) | 1993-10-01 |
| NO933529L NO933529L (no) | 1993-11-29 |
| NO306536B1 true NO306536B1 (no) | 1999-11-22 |
Family
ID=24730117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO933529A NO306536B1 (no) | 1991-04-03 | 1993-10-01 | Senkning av tromboksannivå ved perkutan tilförsel av aspirin |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0578780B1 (fr) |
| JP (1) | JPH06510984A (fr) |
| KR (1) | KR100247441B1 (fr) |
| AT (1) | ATE244011T1 (fr) |
| AU (1) | AU668352B2 (fr) |
| CA (1) | CA2107587C (fr) |
| DE (1) | DE69233116T2 (fr) |
| DK (1) | DK0578780T3 (fr) |
| FI (1) | FI934324A0 (fr) |
| NO (1) | NO306536B1 (fr) |
| WO (1) | WO1992020343A1 (fr) |
| ZA (1) | ZA922464B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP921157A2 (en) * | 1991-12-20 | 1994-10-31 | Lohmann Therapie Syst Lts | Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy |
| WO1994013302A1 (fr) * | 1991-12-20 | 1994-06-23 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Systeme d'administration transdermique contenant de l'acide acetylsalicylique pour la therapie antithrombotique et la prophylaxie contre le cancer |
| DE19616539A1 (de) * | 1996-04-25 | 1997-11-06 | Luitpold Pharma Gmbh | Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel |
| TWI243687B (en) | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| JP2000351729A (ja) * | 1999-06-08 | 2000-12-19 | Shionogi & Co Ltd | トロンボキサンa2受容体拮抗剤の経皮吸収製剤 |
| AR026073A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
| WO2002085376A2 (fr) * | 2001-04-19 | 2002-10-31 | Universite De Montreal | Procede permettant de reduire la production d'anions de superoxyde et traitement de stress oxydant |
| WO2011076401A1 (fr) | 2009-12-23 | 2011-06-30 | Holger Schankin | Compositions pharmaceutiques sensiblement exemptes d'eau, contenant de l'acide acétylsalicylique |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2295753A1 (fr) * | 1974-12-23 | 1976-07-23 | Despin Jean | Composition a base d'acide acetyl-salicylique a usage topique |
| FR2496459A1 (fr) * | 1980-12-19 | 1982-06-25 | Astier Laboratoires Docteur P | Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique |
| IL68965A (en) * | 1983-06-13 | 1987-02-27 | Rafa Labor Ltd | Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders |
| DE3583698D1 (de) * | 1984-04-23 | 1991-09-12 | Kao Corp | Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat. |
| US4866046A (en) * | 1988-05-31 | 1989-09-12 | Top Laboratories, Inc. | Low-dosage sublingual aspirin |
-
1992
- 1992-04-02 DK DK92912205T patent/DK0578780T3/da active
- 1992-04-02 AU AU20142/92A patent/AU668352B2/en not_active Ceased
- 1992-04-02 EP EP92912205A patent/EP0578780B1/fr not_active Expired - Lifetime
- 1992-04-02 CA CA002107587A patent/CA2107587C/fr not_active Expired - Fee Related
- 1992-04-02 KR KR1019930702972A patent/KR100247441B1/ko not_active Expired - Fee Related
- 1992-04-02 WO PCT/US1992/002576 patent/WO1992020343A1/fr not_active Ceased
- 1992-04-02 AT AT92912205T patent/ATE244011T1/de not_active IP Right Cessation
- 1992-04-02 JP JP4511662A patent/JPH06510984A/ja active Pending
- 1992-04-02 DE DE69233116T patent/DE69233116T2/de not_active Expired - Fee Related
- 1992-04-03 ZA ZA922464A patent/ZA922464B/xx unknown
-
1993
- 1993-10-01 FI FI934324A patent/FI934324A0/fi unknown
- 1993-10-01 NO NO933529A patent/NO306536B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100247441B1 (ko) | 2000-04-01 |
| NO933529L (no) | 1993-11-29 |
| WO1992020343A1 (fr) | 1992-11-26 |
| DE69233116D1 (de) | 2003-08-07 |
| DK0578780T3 (da) | 2003-08-18 |
| JPH06510984A (ja) | 1994-12-08 |
| AU668352B2 (en) | 1996-05-02 |
| ATE244011T1 (de) | 2003-07-15 |
| NO933529D0 (no) | 1993-10-01 |
| CA2107587A1 (fr) | 1992-10-04 |
| DE69233116T2 (de) | 2004-08-26 |
| CA2107587C (fr) | 2004-11-23 |
| FI934324A0 (fi) | 1993-10-01 |
| EP0578780A1 (fr) | 1994-01-19 |
| AU2014292A (en) | 1992-12-30 |
| EP0578780B1 (fr) | 2003-07-02 |
| ZA922464B (en) | 1992-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR930700103A (ko) | (+)-α-(2,3-디메톡시페닐)-1-[2-(4-플루오로페닐)에틸]-4-피페리딘메탄올 | |
| DK0449247T3 (da) | Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme | |
| HU895286D0 (en) | Process for the preparation of steroid 5alfa-reductase inhibiting compounds and pharmaceutical compositions containing such compounds | |
| AU3502289A (en) | Method for administering the drug deprenyl so as to minimize the danger of side effects | |
| SE8504967L (sv) | Farmaceutisk komposition och forfarande for behandling av kroppen | |
| IT8720698A0 (it) | Composizione farmaceutica adattivita' terapeutica per il trattamento della demenza senile di tipo alzheimer. | |
| ZA848369B (en) | Pharmaceutical compositions containing bilobalid for the treatment of neuropathies | |
| PT659427E (pt) | Metodos de aumento da expressao de trombomodulina | |
| NO306536B1 (no) | Senkning av tromboksannivå ved perkutan tilförsel av aspirin | |
| NO177663C (no) | Fremgangsmåte til fremstilling av farmasöytisk preparat med nitroglyserin til perkutan administrering | |
| FI944823A0 (fi) | Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa | |
| ES2181849T3 (es) | Procedimiento para minimizar la perdida osea. | |
| IL88971A (en) | Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them | |
| ZA886097B (en) | Pharmaceutical composition for the treatment of psoriasis | |
| DE2961609D1 (en) | Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation | |
| EP0319962A3 (fr) | Dérivés de la pipéridinyl méthanol pour le traitement de l'anxiété | |
| NO952611D0 (no) | Derivater av benzoylekgonin, ekgonin og ekgonidin som medisiner | |
| HUT48119A (en) | Process for producing pharmaceutical compositions against addiction to nicotine and comprising 2-pyrimidinyl-1-piperazine derivatives | |
| IL111144A0 (en) | Pharmaceutical compositions containing amiodarone for the treatment of heart failure | |
| PT87634A (pt) | Process for the preparation of pharmaceutical compositions containing n-imidazolyl derivatives of bicyclic compounds useful for the treatment of nephrophies | |
| NO990283L (no) | Formulering for behandling og/eller profylakse av demens | |
| IL98200A0 (en) | Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide | |
| IL96161A0 (en) | Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency | |
| SE9303855D0 (sv) | The use of ester of inositoltrisphosphate for the preparing of an analgetic medicamnet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |